Table 1 Baseline characteristics

PATIENTS

45

20

25

SEX

16 M | 29 F

6 M | 14 F

10 M | 15 F

AGE (YEARS)

68.2 ± 10

69.4 ± 10

67.5 ± 9.9

0.5

BOBY MASS INDEX

25.4 ± 3.7

24.9 ± 4.1

25.4 ± 3.5

0.1

SKELETAL METASTASES

22

12

20

VISCERAL METASTASES

13

10

3

ACTIVE FRACTURE

21

8

13

IMPENDING FRACTURE

24

12

12

HEMOGLOBIN PRE-SURGERY (G/DL)

12 ± 1.8

11.3 ± 1.8

12.6 ± 1.7

0.2

HEMOGLOBIN POST-SURGERY (G/DL)

9.3 ± 1.3

9.9 ± 1.7

8.9 ± 0.8

0.2

DIFFERENTIAL HEMOGLOBIN (G/DL)

2.7 ± 1.9

1.4 ± 1.8

3.6 ± 1.3

0.02*

ALBUMINE (G/L)

33.2 ± 7.1

30.6 ± 6.5

37.2 ± 6.3

0.03*

NLR

5.2 ± 4.9

7.1 ± 6.7

3.8 ± 2.4

0.05*

PLR

245 ± 161

312 ± 203

195 ± 99

0.04*

FOLLOW-UP (MONTHS)

21.2 ± 16.3

9 ± 5.4

30.5 ± 15.9

0.001*